Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma

Nature Genetics

Volumn 45, Issue 8, 2013, Pages 923-926

  Tarpey, Patrick S ^a   Behjati, Sam ^a,b   Cooke, Susanna L ^a   Van Loo, Peter ^a,c   Wedge, David C ^a   Pillay, Nischalan ^d,e   Marshall, John ^a   Meara, Sarah O ^a   Davies, Helen ^a   Zainal, Serena Nik ^a   Beare, David ^a   Butler, Adam ^a   Gamble, John ^a   Hardy, Claire ^a   Hinton, Jonathon ^a   Jia, Ming Ming ^a   Jayakumar, Alagu ^a   Jones, David ^a   Latimer, Calli ^a   Maddison, Mark ^a   Martin, Sancha ^a   McLaren, Stuart ^a   Menzies, Andrew ^a   Mudie, Laura ^a   Raine, Keiran ^a   Teague, Jon W ^a   Tubio, Jose M C ^a   Halai, Dina ^d   Tirabosco, Roberto ^d   Amary, Fernanda ^d   Campbell, Peter J ^a,b,f   Stratton, Michael R ^a   Flanagan, Adrienne M ^d,e   Futreal, P Andrew ^a   more..

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COL2A1 PROTEIN; COLLAGEN; UNCLASSIFIED DRUG;

ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CHONDROSARCOMA; CHROMOSOME 12; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; COPY NUMBER VARIATION; EXOME; EXTRACELLULAR MATRIX; GENE DELETION; GENE INSERTION; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INDEL MUTATION; MISSENSE MUTATION; PRIORITY JOURNAL; SOMATIC MUTATION;

BONE NEOPLASMS; CHONDROSARCOMA; COLLAGEN TYPE II; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; DNA COPY NUMBER VARIATIONS; HEDGEHOG PROTEINS; HUMANS; MUTATION; NEOPLASM GRADING; POLYMORPHISM, SINGLE NUCLEOTIDE; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION;

ERINACEIDAE;

EID: 84881029230     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.2668     Document Type: Article

References (25)

1. Stephens, P.J. et al. The landscape of cancer genes and mutational processes in breast cancer. Nature 486, 400-404 (2012).
2. Van Loo, P. et al. Allele-specific copy number analysis of tumors. Proc. Natl. Acad. Sci. USA 107, 16910-16915 (2010).
3. Kim, N. & Jinks-Robertson, S. Transcription as a source of genome instability. Nat. Rev. Genet. 13, 204-214 (2012).
4. Barbieri, O. et al. Depletion of cartilage collagen fibrils in mice carrying a dominant negative Col2a1 transgene affects chondrocyte differentiation. Am. J. Physiol. Cell Physiol. 285, C1504-C1512 (2003).
5. Yang, G. et al. PTEN deficiency causes dyschondroplasia in mice by enhanced hypoxia-inducible factor 1α signaling and endoplasmic reticulum stress. Development 135, 3587-3597 (2008).
6. Chiu, L.H. et al. Differential effect of ECM molecules on re-expression of cartilaginous markers in near quiescent human chondrocytes. J. Cell Physiol. 226, 1981-1988 (2011).
7. Amary, M.F. et al. IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J. Pathol. 224, 334-343 (2011).
8. Popovici-Muller, J. et al. Discovery of the first potent inhibitors of mutant IDH1 that lower tumor 2-HG in vivo. ACS Med. Chem. Lett. 3, 850-855 (2012).
9. Fathi, A.T. et al. Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response. Blood 120, 4649-4652 (2012).
10. Hallor, K.H. et al. Genomic profiling of chondrosarcoma: chromosomal patterns in central and peripheral tumors. Clin. Cancer Res. 15, 2685-2694 (2009).
11. Schrage, Y.M. et al. Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro. J. Cell Mol. Med. 13, 2843-2852 (2009).
12. Aceto, G. et al. Mutations of APC and MYH in unrelated Italian patients with adenomatous polyposis coli. Hum. Mutat. 26, 394 (2005).
13. Ahn, J. et al. Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1). Nat. Genet. 11, 137-143 (1995).
14. Hopyan, S. et al. A mutant PTH/PTHrP type I receptor in enchondromatosis. Nat. Genet. 30, 306-310 (2002).
15. Stickens, D. et al. The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes. Nat. Genet. 14, 25-32 (1996).
16. Bruce, S.J. et al. Inactivation of Patched1 in the mouse limb has novel inhibitory effects on the chondrogenic program. J. Biol. Chem. 285, 27967-27981 (2010).
17. Wuelling, M. & Vortkamp, A. Transcriptional networks controlling chondrocyte proliferation and differentiation during endochondral ossification. Pediatr. Nephrol. 25, 625-631 (2010).
18. Tang, J.Y. et al. Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. N. Engl. J. Med. 366, 2180-2188 (2012).
19. Varela, I. et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 469, 539-542 (2011).
20. Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589-595 (2010).
21. Stephens, P.J. et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144, 27-40 (2011).
22. Ye, K., Schulz, M.H., Long, Q., Apweiler, R. & Ning, Z. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 25, 2865-2871 (2009).
23. Nik-Zainal, S. et al. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979-993 (2012).
24. Shalaby, A. et al. The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target. J. Pathol. 223, 336-346 (2011).
25. McLaren, W. et al. Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics 26, 2069-2070 (2010).